100% Locally Owned, Independent and Free

100% Locally Owned, Independent and Free

New study could set new standard for treating chronic respiratory infections

Do you have a news tip? Click here to send to our news team.

Flood rescue and lightning strike after night of heavy rain

A person has been rescued from floodwaters and another was struck by lightning after wild weather hit the Sunshine Coast. ANZAC Day commemorations went ahead More

Lest we forget: Coast pauses to remember on wet ANZAC Day

Across the Sunshine Coast this morning community members have gathered to pay heartfelt tribute to past and present servicemen and women as part of More

Never forgotten: veteran’s mission to keep ANZAC spirit alive

Every year on April 25, Australians and New Zealanders commemorate those who have given their lives, fought on the frontline, served in the Armed More

ANZAC Day: where you can attend services on the Coast

This Friday the country will stop to remember the sacrifice and bravery of Australian and New Zealand servicemen and servicewomen, past and present. April 25 More

Easter feast: python devours possum at busy beach

A slithery creature has enjoyed quite the Easter feast while stunning visitors at a popular beach over the recent long weekend. Passers-by were stopped in More

‘Ongoing challenge’: group works towards reliable harbour access

The state's waterways authority says it is doing what it can to address persistent shoaling at the entrance to the Sunshine Coast's main harbour. Maritime More

A new study is aiming to more effectively diagnose and treat infections associated with an incurable lung disease.

A University of the Sunshine Coast research team has received a $921,000 federal government grant for a $1.5 million project focused on chronic obstructive pulmonary disease.

COPD is a debilitating lung airflow condition that affects a million Australians and last year resulted in more than 7000 deaths.

Flare-ups with associated bacterial, fungal and viral infections hospitalise more than 50,000 Australians aged over 45 annually.

Symptoms of flare-ups include breathing difficulties, coughing and sputum production that can worsen over time, causing irreversible lung damage.

Want more free local news? Follow Sunshine Coast News on Facebook, LinkedIn and Instagram, and sign up for our FREE daily news email.

UniSC Associate Professor Derek Sarovich said the National Health and Medical Research Council Ideas Grant would enable his team to apply its novel ARDaP software, along with cutting-edge molecular diagnostic techniques, to help doctors better identify and treat the myriad pathogens that cause COPD flare-ups.

“Over-prescription of broad antibiotics has led to the emergence of multi drug resistant pathogens that are difficult and, in some cases, impossible, to treat,” Dr Sarovich said.

“This project aims to tackle the antimicrobial resistance crisis by profiling the COPD airway microbiome at an unprecedented molecular level.

“Our combination of laboratory, software, and artificial intelligence technologies will then be used to assist clinicians in providing their patients with highly personalised diagnosis and treatment for existing and future infections.”

The study team will build on years of research.

This study builds on seven years of respiratory microbiome and antimicrobial resistance research at the Sunshine Coast Health Institute with fellow UniSC Centre for Bioinnovation co-lead Associate Professor Erin Price.

The collaboration includes UniSC PhD researcher and Sunshine Coast Hospital and Health Service respiratory specialist Dr Timothy Baird, SCHHS clinical nurse consultant Jane Neill and Mater Hospital Brisbane respiratory specialist Associate Professor Lucy Burr, who all have a keen interest in improving quality of life and outcomes for their patients with COPD.

Dr Baird said the research aimed to set a new standard for treating chronic respiratory infections.

“As a respiratory physician, I see first-hand the effects of COPD on patients and their families,” he said.

“This research has the potential to transform how we understand, diagnose and manage infections in COPD patients, and importantly, how we better tailor care to improve patient outcomes and reduce unnecessary antimicrobials.”

Subscribe to SCN’s free daily news email

Hidden
This field is for validation purposes and should be left unchanged.
[scn_go_back_button] Return Home
Share